Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

Clinical trial NCT03738943 · COMPLETED

Trial details

NCT number: NCT03738943
Sponsor: Colorado State University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Receptor Blockade

Start date: 2019-02-07
Primary completion: 2021-06-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.